Status:
COMPLETED
To Exam the Effects of Phyllanthus Niruri Extracts on Human Neutrophils
Lead Sponsor:
Chang Gung Memorial Hospital
Conditions:
Neutrophil
Phyllanthus Abnormis Poisoning
Eligibility:
All Genders
20-35 years
Brief Summary
To exam the effects of Phyllanthus niruri extracts(corilagin, phyllanthin and brevifolin) on human neutrophils
Detailed Description
Phyllanthus niruri extracts have anti-inflammatory effects in various cellular systems (monocytes, neutrophil). However, the underlying effects and mechanisms of Phyllanthus niruri extracts on neutrop...
Eligibility Criteria
Inclusion
- Healthy volunteers who aged 20-35 years.
- Do not have coagulopathy, systemic infection disease and severe liver and renal function impairment
- Accept venipuncture
Exclusion
- Healthy volunteers who aged over 35 years.
- Have coagulopathy, systemic infection disease and severe liver and renal function impairment
Key Trial Info
Start Date :
January 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 31 2023
Estimated Enrollment :
240 Patients enrolled
Trial Details
Trial ID
NCT05206058
Start Date
January 1 2022
End Date
July 31 2023
Last Update
September 1 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Chang Gung Memorial Hospital
Taoyuan District, Taiwan, 333